| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/12/2005 | CN1562058A Medicinal composition for treating cardiocerebral diseases |
| 01/12/2005 | CN1562057A Medicinal composition for treating cardiocerobral diseases |
| 01/12/2005 | CN1562056A Slow and control release preparation for thromus |
| 01/12/2005 | CN1562039A Moricizine hydrochloride dripping pill and its preparing method |
| 01/12/2005 | CN1562035A Dipyridamole powder injection and its preparing method |
| 01/12/2005 | CN1562028A Flunarizine hydrochoride injection and preparing method |
| 01/12/2005 | CN1562027A Trimetazidine hydrochloride dripping pill and its preparing method |
| 01/12/2005 | CN1562024A Oral preparation containing ranolazine hydrochloride for treating cardiovascular disease |
| 01/12/2005 | CN1562018A Cilostazol solid dispersion and its method for preparing tablet |
| 01/12/2005 | CN1562013A Nisoldipine oral disintegration tablet for treating hypertension and preparing method |
| 01/12/2005 | CN1562012A Deamlexanox oral disintegration tablet for treating hypertension and angina and preparing method |
| 01/12/2005 | CN1562011A Nicardipine hydrochloride dripping pill and its preparing method |
| 01/12/2005 | CN1562010A Nimodipine injection emulsion and its preparing method |
| 01/12/2005 | CN1562009A Amlodipine benzenesulfonate slow-releasing capsule and its preparing method |
| 01/12/2005 | CN1562002A Novel anti-biological cell free redical oxidation injury mixture |
| 01/12/2005 | CN1561996A Medicnal composition for treating cardiocerebral vascular diseases |
| 01/12/2005 | CN1561989A Soybean aglycone soft capsule and its preparing method |
| 01/12/2005 | CN1561988A Method for preparing taxol micro ball anti-cancer medicine |
| 01/12/2005 | CN1561982A Bumetanide dripping pill and its preparing method |
| 01/12/2005 | CN1561981A Sodium ferulate preparation and its preparing method |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184229C Furost saponine analogue and its separation process and use |
| 01/12/2005 | CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 01/12/2005 | CN1184213C Methods for crystalization of N-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-L- alanine N-carboxyanhydride |
| 01/12/2005 | CN1184209C Chuanxiong alkoxide derivative and its preparation and medicinal composition containing it and use thereof |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183966C Application of human urokininogenase in preparing medicine for preventing and treating cerebral infraction |
| 01/12/2005 | CN1183957C Chinese medicine capsules for treating phlebitis and angiitis |
| 01/12/2005 | CN1183949C Medicine for treating thrombus disease |
| 01/12/2005 | CN1183943C Tea, medicated tea and buccal tablet for lowering blood pressure and reducing blood fat |
| 01/12/2005 | CN1183941C Chinese medicinal liquid pill for treating cardio-cerebral angiopathy |
| 01/12/2005 | CN1183936C Medicine for treating hypertension and method for preparing medicinal tea thereof |
| 01/12/2005 | CN1183935C Notoginseng and fermented red rice composition for preventing and treating cardiac an cerebral vascular diseases |
| 01/12/2005 | CN1183923C Medicine for treating diabetes and coronary heart disease |
| 01/12/2005 | CN1183913C Application of N-acetyl-D-aminoglucose in preparing medicines to treat cardiac and cerebral ischemical and anoxia |
| 01/12/2005 | CN1183908C Injection medication combination of nimodiping and its preparing method |
| 01/11/2005 | US6841701 Inhibitors for the blood-clotting factor Xa |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841554 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |
| 01/11/2005 | CA2369091C Anticonvulsant derivatives useful in lowering blood pressure |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2151443C Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/07/2005 | CA2470768A1 Crystal structure of osc |
| 01/06/2005 | WO2005001732A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 01/06/2005 | WO2005000826A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | WO2005000825A1 Thiazolimine compound and oxazolimine compound |
| 01/06/2005 | WO2005000819A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
| 01/06/2005 | WO2005000791A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/06/2005 | WO2005000789A1 2-amino-3-alkoxybicyclo[3.1.0]hexane derivative |
| 01/06/2005 | WO2005000353A1 Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 01/06/2005 | WO2005000318A2 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 01/06/2005 | WO2004106486A3 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 01/06/2005 | WO2004096257A3 Genetic modification of targeted regions of the cardiac conduction system |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004087646A3 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004074312A3 Tryptophyllin peptides and uses thereof |
| 01/06/2005 | WO2004073588A3 Diagnostics and therapeutics for diseases associated with g protein coupled receptor r35 (r35) |
| 01/06/2005 | WO2004073586A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 01/06/2005 | WO2004071392A3 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 01/06/2005 | WO2004071385A3 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | WO2004062657A8 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |
| 01/06/2005 | WO2004022066A3 Method and means for the treatment of vascular and cardiac diseases |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | WO2003032912A9 Treatment of cns disorders using cns target modulators |
| 01/06/2005 | US20050004510 Noninvasive vascular therapy |
| 01/06/2005 | US20050004428 Cardiac disease treatment and device |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004231 Method for inhibiting platelet aggregation |
| 01/06/2005 | US20050004226 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004206 suspending crystal strutured or amorphous lipitor in diluents comprising alcohols and/or water mixtures to cause conversion, then separating the diluents; monodispersity |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004196 Treatment and prevention of inflammation and associated diseases |
| 01/06/2005 | US20050004195 Inhibitors of phosphoinositide 3 kinases; inflammatory diseases, cardiovascular disorders, cancers; such as 5,6-dimethoxy-3-o-tolylsulfanyl-1H-indole-2-carboxylic acid-(2H-tetrazol-5-yl)-amide |
| 01/06/2005 | US20050004194 Use of organic compounds |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004170 Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004159 for example, 8-(1-ethylpropyl)-3-mesityl-2,5-dimethyl-8H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine; having an excellent corticotrophin-releasing-factor receptor antagonistic activity |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004147 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004139 Pharmaceutical preparations containing aminobenzene-sulfonic acid derivatives as the active ingredient |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |